Highly discriminating photorelease of anticancer drugs based on hypoxia activatable phototrigger conjugated chitosan nanoparticles

Adv Mater. 2013 Apr 11;25(14):1981-6. doi: 10.1002/adma.201204455. Epub 2013 Feb 7.

Abstract

An ultimately selective photorelease system of chitosan-nanoparticles is constructed. Only under unique aspects of tumor-hypoxia physiological conditions, the preliminary locked phototrigger is unlocked by biological reduction to enable the release of the caged drug either by visible light or two-photon near-IR (NIR) excitation. This approach provides a highly discriminating photorelease of anticancer drug to hypoxic tumor cells, but not to healthy normal cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / toxicity*
  • Cell Hypoxia / drug effects*
  • Cell Survival / drug effects
  • Chitosan / chemistry*
  • Drug Carriers / chemistry*
  • HeLa Cells
  • Humans
  • Light
  • MCF-7 Cells
  • Nanoparticles / chemistry*
  • Nanoparticles / ultrastructure
  • Photons

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Chitosan